MA (EU) number 
(Invented) 
name 
Strength 
Pharmaceutical 
Form 
Route of 
Administration 
Immediate 
Packaging 
Content 
(concentration) 
Pack size 
EU/1/20/1426/001  Azacitidine Mylan    25 mg/ml 
EU/1/20/1426/002  Azacitidine Mylan    25 mg/ml 
Powder for 
suspension for 
injection 
Powder for 
suspension for 
injection 
Subcutaneous use  vial (glass) 
100 mg 
1 vial  
Subcutaneous use  vial (glass) 
100 mg 
7 vials  
1/1 
 
 
 
 
